BRCA2 and breast carcinoma: We have previously reported a novel method of using expression arrays and the Cancer Genetic Markers of Susceptibility (CGEMS) Breast Cancer Whole Genome Association Scan to prioritize IR response genes that potentially modify breast cancer risk in BRCA1 and BRCA2 carriers [28].